Daniel Richard Roberts is a notable inventor based in Robbinsville, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work primarily focuses on the development of crystalline forms of various compounds, which are crucial for enhancing the efficacy and stability of medications.

Latest Patents

Roberts' latest patents include the crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-D3)pyridazine-3-carboxamide. This patent discloses crystalline Form B of the compound, which is the HCl salt of a neat crystalline form. Characterization data for Form B are also provided. Another patent involves a similar crystalline form of the same compound, emphasizing the importance of these formulations in pharmaceutical applications.

Career Highlights

Daniel Richard Roberts is currently employed at Bristol-Myers Squibb Company, where he continues to innovate and contribute to the pharmaceutical industry. His expertise in crystallization and compound formulation has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Roberts has collaborated with esteemed colleagues such as T G Murali Dhar and Hai-Yun Xiao. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Daniel Richard Roberts exemplifies the spirit of innovation in the pharmaceutical industry through his patents and contributions. His work not only advances scientific knowledge but also plays a vital role in the development of effective medications.

This text is generated by artificial intelligence and may not be accurate.